Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $7.6000 (-5.59%) ($7.6000 - $7.6000) on Tue. Dec. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.23% (three month average) | RSI | 49 | Latest Price | $7.6000(-5.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 4.3% a day on average for past five trading days. | Weekly Trend | IOVA advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(35%) IWC(30%) IWO(27%) IWM(24%) JETS(23%) | Factors Impacting IOVA price | IOVA will decline at least -2.615% in a week (0% probabilities). UNG(-13%) VXX(-9%) XOP(-5%) VFMO(-5%) XLU(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.615% (StdDev 5.23%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.04(7.95%) | 10 Day Moving Average | $6.63(14.63%) | 20 Day Moving Average | $7.08(7.34%) | To recent high | -36% | To recent low | 27.6% | Market Cap | $1.113b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |